|Bid||96.42 x 900|
|Ask||97.50 x 900|
|Day's Range||93.24 - 96.78|
|52 Week Range||75.22 - 198.00|
|Beta (5Y Monthly)||0.88|
|PE Ratio (TTM)||59.33|
|Earnings Date||Feb 26, 2024 - Mar 01, 2024|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Nov 23, 2012|
|1y Target Est||92.00|
Subscribe to Yahoo Finance Plus to view Fair Value for MASI
Masimo Corporation ( NASDAQ:MASI ), might not be a large cap stock, but it saw a significant share price rise of over...
IRVINE, Calif., November 27, 2023--Masimo (NASDAQ: MASI) today announced that its management will participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023 at 9:30 am ET. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation.
Masimo's (MASI) receipt of the latest FDA approval is expected to provide greater visibility of changes in oxygen saturation to help patients better manage their oxygen levels daily.